Nicotinamide Mononucleotide (NMN)

NMN · Beta-NMN

Ancillary peptide Published Clinical Data

Overview

NAD+ precursor. The oral supplement form of NAD+ support distinct from injectable NAD+. Direct precursor to NAD+ that bypasses some conversion steps. 250–1000mg daily, morning. Head-to-head trial (Jan 2026) showed equivalent NAD+ elevation to NR at matched doses. Popular in longevity/biohacker community alongside injectable NAD+.

Used in Regimens

Nicotinamide Mononucleotide (NMN) is not currently part of any catalog regimen.

Related Tools

Track Nicotinamide Mononucleotide (NMN) with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.